Navigation Links
Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A

Maria C Jenmalm,1 Michele Malit,2 Jim Torrence,2 and Aiguo Zhang,2
Department of Molecular and Clinical Medicine, Division of Paediatrics, Linkping University, Sweden, and 2 Bio-Rad Laboratories, Inc., 2000 Alfred Nobel Drive, Hercules, CA 94547 USA

Cytokines play a significant role in hematopoiesis, inflammation, and wound healing. These important immunoregulators mediate interactions between various cells, and their dysregulated production may contribute to disease pathogenesis. Elevated levels of cytokines may indicate inflammation or disease progression. Although cytokine functions are complex, cytokine profiles are highly relevant parameters of an immune response. Different cytokines possess biologically overlapping functions, and they have the ability to regulate production of other cytokines. Therefore, analysis of the function of the complete set of cytokines expressed within microenvironments (e.g., a site of inflammation) is often of more value than analysis of a single isolated cytokine (OGarra and Murphy 1994).

A number of methodologies can be used to measure cytokines. The most common one is the enzyme-linked immunosorbent assay (ELISA), which allows measurement of different cytokines with high sensitivity and specificity. This technology, however, is restricted to analyzing one cytokine target at a time, which limits its usefulness when simultaneous measurement of multiple cytokine targets is desired. The new suspension bead array technology employed in the Bio-Plex system (Luminex xMAP technology) allows multiple cytokine targets to be measured from a single sample in a micr oplate well (Vignali 2000).

The goal of our study was to compare the Bio-Plex cytokine assays with cytokine ELISA developed in-house for testing cell culture samples from asthmatic and healthy children.

Cell Isolation and Cultures
Human peripheral blood mononuclear cells (PBMC) were isolated from fresh blood donated by atopic asthmatic children and non-atopic healthy children between the ages of 13 and 15 (Bttcher et al. in press). The cells (1 x 106/ml) were cultured in AIM-V serum-free medium (Life Technologies AB, Sweden) with 20 mM mercaptoethanol (Sigma-Aldrich, Stockholm, Sweden). The cells were stimulated with timothy grass, cat, and dog allergen extracts from ALK (Horsholm, Denmark) at 10,000 standardized units/ml each. The cells were cultured at 37C with 5% CO2 for 144 hr. The supernatants were collected after centrifugation and stored at 70C. Samples were tested simultaneously for cytokines IL-5, IL-10, IL-13, and IFN-γ using both a Bio-Plex human cytokine 4-plex assay and an ELISA made from commercially available antibodies.

Multiplex Assay
A Bio-Plex human cytokine assay for simultaneous quantitation of IL-5, IL-10, IL-13, and IFN-γ was run according to the recommended procedure. In brief, the premixed standards were reconstituted in 0.5 ml of culture medium, generating a stock concentration of 50,000 pg/ml for each cytokine. The standard stock was serially diluted in the same culture medium to generate 8 points for the standard curve. The assay was performed in a 96-well filtration plate supplied with the assay kit. Premixed beads (50 l) coated with target capture antibodi es were transferred to each well of the filter plate (5,000 beads per well per cytokine) and washed twice with Bio-Plex wash buffer. Premixed standards or samples (50 l) were added to each well containing washed beads. The samples were used directly without further dilution. The plate was shaken for 30 sec and then incubated at room temperature for 30 min with low-speed shaking (300 rpm). After incubation and washing, premixed detection antibodies (50 l, final concentration of 2 g/ml) were added to each well. The incubation was terminated after shaking for 10 min at room temperature. After 3 washes, the beads were resuspended in 125 l of Bio-Plex assay buffer. Beads were read on the Bio-Plex suspension array system, and the data were analyzed using Bio-Plex Manager software (v 3.0) with 5PL curve fitting.

ELISAs were performed as described in Jenmalm et al. (2001). Human cytokines IL-10 and IL-13 were analyzed using PeliPair reagent set antibodies (CLB, Amsterdam, the Netherlands). IL-5 was analyzed using an antibody pair from Pharmingen (San Diego, CA): capture antibody TRFK5 and detection antibody JES1-5. IFN-γ was measured using an antibody pair from R&D Systems (Abingdon, UK): capture antibody 2571.811 and a polyclonal detection antibody (goat anti-human). The detection antibodies were biotinylated and streptavidin-horseradish peroxidase was the enzyme label reagent.

Results and Discussion
Correlation between the Bio-Plex assay and ELISA was evaluated by measuring 22 samples for four cytokine targets (IL-5, IL-10, IL-13, and IFN-γ; see table). The concentrations of the majority of samples measured by ELISA compared well with concentration s obtained in the Bio-Plex assays (see figure). Correlation coefficients (r2) ranged from 0.80 to 0.99 (p<0.001 for all analyses).

The dynamic range of the ELISA used in this study was significantly narrower than that of the Bio-Plex assays. The ELISAs detected 1.6 to 600 pg/ml cytokines, while Bio-Plex assays detected 1.6 to 32,000 pg/ml.

In this study, we were able to demonstrate that testing PBMC samples from asthmatic and healthy children for IL-5, IL-10, IL-13, and IFN-γ by ELISA and Bio-Plex assays yielded similar results. Bio-Plex assays have broader dynamic range and allow for multiplex analysis of cytokines in a single sample. Therefore, Bio-Plex assays have an advantage over the current ELISA methodology when multiple samples have to be analyzed for several cytokines and when available sample volume is limited.

We thank Ulrika Bengtsson, Anne-Marie Fornander, Lena Lindell, Ing-Marie Sandberg, and Kristina Warstedt, Department of Molecular and Clinical Medicine, Division of Paediatrics, Linkping University, Sweden, for excellent technical assistance.

Bttcher MF et al., Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children, Pediatr Allergy Immunol, in press

Jenmalm MC et al., Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children, Clin Exp Allergy 31, 15281535 (2001)

OGarra A and Murphy K, Role of cytokines in determining T-lymphocyte function, Curr Opin Immunol 6, 458466 (1994)

Vignali DA, Multiplexed particle-based flow cy tometric assays, J Immunol Methods 243, 243255 (2000)

xMAP is a trademark of Luminex Corp. The Bio-Plex protein array system includes fluorescently labeled microspheres and instrumentation licensed to Bio-Rad Laboratories, Inc. by the Luminex Corporation.

back to top


Page: All 1 2 3 4 5

Related biology technology :

1. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
2. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
3. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
4. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
5. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
6. Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays
7. Simultaneous Detection of 8 Cytokines in Mouse or Human Sera
8. Principles of Curve Fitting for Multiplex Sandwich Immunoassays, Rev B
9. Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System
10. Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection
11. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
Post Your Comments:

(Date:11/30/2015)... Partnership includes an MPP licen ... niversity , s Solid Drug Nanoparticle (SDN) Technology ... up through cost cuts of priority ... licensees based anywhere in the world will have the right to make, use and ... , where licensees based anywhere in the world will have the right to make, ...
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
(Date:11/30/2015)... -- TapImmune, Inc. (TPIV), a clinical-stage ... and gene-based immunotherapeutics and vaccines for the treatment of ... presenting at the 8 th Annual LD Micro ... PT. Dr. John N. Bonfiglio a TapImmune ... presentation and will join TapImmune management in meeting with ...
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, 2015 ... in Vienna, Austria to be ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") ... its Internet-delivered NovaVision Therapy Suite at the 3rd European ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
(Date:10/27/2015)... Germany , October 27, 2015 ... SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically maps ... SMI,s Eye Tracking Glasses , so that they ... BeGaze. --> Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ...
Breaking Biology News(10 mins):